Enfermedad de Alzheimer/metabolismo; Ciclo Celular; Microglía/metabolismo; Neuronas/metabolismo; Factor de Necrosis Tumoral alfa/metabolismo; Péptidos beta-Amiloides/farmacología; Animales; Células Cultivadas; Lóbulo Frontal/metabolismo; Humanos; Ratones; Ratones Endogámicos C57BL; Ratones Transgénicos; Microglía/efectos de los fármacos; Lóbulo Temporal/metabolismo

AD; Adoptive transfer; Alzheimer's disease; AßF; AßO; BrdU; Bromodeoxyuridine; CCE; CM; COX2; GFP; IDV; IKKα/ß; IL-1ß; IL-6; INFγ; IκB kinase α/ß; JNK; LPS; MAP2; Microglia; NOS; NSAID; Neuroinflammation; Neuronal cell cycle; PAS; PBS; PCNA; PFA; PI3K; Phosphatidylinositol 3-kinase; ROI; RT; STAT3; Signal transducer and activator of transcription 3; TNF receptor; TNFR; TNFα; TUNEL; Terminal deoxynucleotidyl transferase dUTP nick end labeling; Tumor Necrosis Factor-α; Tumor necrosis factor-α (TNFα); c-Jun Kinase; c-Jun Kinase (JNK); cell cycle events; conditioned media; cyclooxygenase-2; fibrillar amyloid-beta peptide; green fluorescent protein; integrated density value; interferon-γ; interleukin-1ß; interleukin-6; lipopolysaccharide; microtubule associated protein-2; nitric oxide synthase; non-steroidal anti-inflammatory drug; oligomeric amyloid-beta peptide; p38 MAPK; p38 mitogen activated protein kinase; paraformaldehyde; phosphate buffered saline; proliferating cell nuclear antigen; protein-A-sepharose; region of interest; room temperature